AS

Archna Sharma

Active Director Director DIN 07408644
DIN 07408644 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2016
Shareholding value •••• Premium profile

About Archna Sharma

Data last updated:

Archna Sharma is a Director at Synapes Life Sciences Private Limited (since 2016). The company operates in Pharma. Synapes Life Sciences Private Limited reported revenue of ₹3.59 Cr (FY 2024).

DIN 07408644
Primary Designation Director
Industry Pharma
First Appointment 27 Jan 2016
Oldest Company Age 10 yrs
Largest company Synapes Life Sciences Private Limited · ₹3.59 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jan 20162016₹3.59 Cr (FY 2024)Active

Board colleagues of Archna Sharma

Directorship timeline

Open interactive timeline →
Synapes Life Sciences Private Limited
Premium access

Shareholding and investment profile for Archna Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Archna Sharma

Archna Sharma currently holds 1 directorship: Synapes Life Sciences Private Limited (Director, since 27 Jan 2016, revenue ₹3.59 Cr (FY 2024)).

Archna Sharma was first appointed on 27 Jan 2016 as Director at Synapes Life Sciences Private Limited.

The current boards of Archna Sharma's companies include Ajay Kumar Sharma (Synapes Life Sciences Private Limited), Neeru Sharma (Synapes Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available